Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 35 and 65 years of age
- People who are fluent in English
- People with sufficient vision and hearing to complete the tests involved in the trial
Who may not be able to join:
- People who have been diagnosed with any form of dementia or memory/thinking disorder (mild or major)
- People who have a major neurological condition, such as epilepsy, Parkinson's Disease, or a history of stroke
- People who have been diagnosed with a major mental health condition, such as bipolar disorder or schizophrenia
- People whose depression or anxiety is currently untreated or not well managed
- People with a personal history of cancer or chemotherapy treatment (confirm with trial site for specific applicability)
- People who have a history of a learning disorder
- People who have had a head injury that caused loss of consciousness lasting more than 20 minutes
- People who have had their fallopian tubes, ovaries, or uterus surgically removed
- People who have a cardiac pacemaker
- People who have any other implanted electronic device
- People who experience claustrophobia (fear of enclosed spaces)
- People who are currently pregnant
- People who have metal implants near the eyes or other metallic foreign objects in the body
- People in the control group who currently use a hormonal contraceptive that affects the body's natural hormone levels or makes it difficult to determine a regular menstrual cycle (such as the oral contraceptive pill or a hormone-releasing IUD)
- People in the control group who are currently receiving systemic estrogen replacement therapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kathleen Van Dyk, PhD, University of California at Los Angeles
Phone: 310 825-2719
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Brain activity comparison between breast cancer survivors undergoing endocrine therapy and healthy matched control subject.; Cognitive function comparison between breast cancer survivors undergoing endocrine therapy and healthy matched control subject.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.